CD70 and neoplasm: T cells expressing CD70-specific first- and second-generation CARs which utilized the CD70-binding domain of CD27 for target-cell recognition specifically lysed CD70-positive primary GB cells in vitro, and inhibited growth or induced complete tumor regression in xenograft and syngeneic GB models in mice (141).